Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma.

Cells · 2026 · PMC13256129 · PMID 42274623

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While we were not able to perform the whole battery of experiments on all three established cell lines due to the cell senescence, in all three CAF lines cultured alone, rilmenidine treatment showed a trend in a decrease of both αSMA and FAP protein expression.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.